Since 2007, NYU Langone Health’s Perlmutter Cancer Center has been a member of ECOG-ACRIN—formed by the merger of the Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network—a multidisciplinary, membership-based scientific organization that designs and conducts cancer research involving adults who have or are at risk of developing cancer.
Catherine Diefenbach, MD, an associate professor in the Department of Medicine and director of the Clinical Lymphoma Program at Perlmutter Cancer Center, serves on ECOG-ACRIN’s Principal Investigator Committee. Dr. Diefenbach contributes a blog post describing some of the clinical trials conducted at Perlmutter Cancer Center that are supported by ECOG-ACRIN.
“Perlmutter Cancer Center has a diverse portfolio of clinical trials that provides patients with access to the newest, most innovative therapies to treat their cancer,” Dr. Diefenbach writes.
Read more from the ECOG-ACRIN Blog.